OIG: Did Labs Do Enough Non-COVID-19 Testing during Pandemic?
The number of non-COVID-19 tests billed to Medicare during the pandemic has decreased compared to the six-month period before COVID-19.
The number of non-COVID-19 tests billed to Medicare during the pandemic has decreased compared to the six-month period before COVID-19.
Caris Life Sciences agrees to pay $2.8 million to settle claims that it purposely delayed submitting lab tests to get around Medicare’s 14-day rule.
If your lab received federal relief funds from the US government during the COVID-19 pandemic, you could be at risk of FCA lawsuits.
OIG report finds that $8 million of $40 million in claims made by such suppliers in a recent audit did not meet Medicare requirements.
New OIG Advisory Opinion offers valuable insight into where the agency draws the line on free genetic tests.